Stonepine Capital Management LLC has recently announced that it has increased stake in Gamida Cell Ltd (NASDAQ:GMDA) by 431.06%. After grabbing 7.97 million shares, the institutional investor is now in possession of 6.47 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 6.01% having worth around $2.47 million. Moreover, Nantahala Capital Management LLC increased its share by 4.33 million to have a control over 4.33 million shares. And Levin Capital Strategies LP raised its holdings to 39000.0 shares by acquiring 2.69 million shares or 2.03% of the stake.
Gamida Cell Ltd (GMDA) concluded trading on 01/03/24 at a closing price of $0.36, with 3.94 million shares of worth about $1.42 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -79.30% during that period and on Wednesday the price saw a loss of about -10.24%. Currently the company’s common shares owned by public are about 132.64M shares, out of which, 120.05M shares are available for trading.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 4 analysts are covering the GMDA stock and their offered price forecasts bring an average price target of $4.00. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $6.00 and could fall to a lowest price of $2.00. The stock’s current price level is 91.0% above of average price target set by the analysts, while a rise to estimated low would result in gain of 82.0% for the stock. However, touching the estimated high of $6.00 would mean a gain of 94.0% for the stock.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 23 times over the past 12 months. They bought 1,044,083 shares in 23 of the transactions. In 0 selling transactions, insiders dumped 0 shares.
Fidelity VIP – Growth Portfolio, Fidelity Capital Appreciation Fun, and ARK Israel Innovative Technology are the top 3 mutual funds which are holding stakes in Gamida Cell Ltd Fidelity VIP – Growth Portfolio is currently holding 2.21 million shares of worth totaling $0.69 million. The company recently came buying 0.0 shares which brought its stake up to 1.67% of the company’s outstanding shares. ARK Israel Innovative Technology, after buying 2.07 million shares, have now control over 1.56% of the stake in the company. It holds 0.0 shares of worth $0.64 million.
However, the stock later moved at a day high price of 0.4200, or with a loss of -10.24%. Stock saw a price change of 16.45% in past 5 days and over the past one month there was a price change of 7.88%. Year-to-date (YTD), GMDA shares are showing a performance of -13.74% which decreased to -72.40% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.22 but also hit the highest price of $2.51 during that period. The average intraday trading volume for Gamida Cell Ltd shares is 2.42 million. The stock is currently trading 10.67% above its 20-day simple moving average (SMA20), while that difference is down -22.63% for SMA50 and it goes to -69.74% lower than SMA200.
Stonepine Capital Management LLC acquired 7.97 million shares of Gamida Cell Ltd having value of about $2.47 million. Data submitted at the U.S SEC by Stonepine Capital Management LLC revealed that the firm now holds 6.47 million shares in the company valued at close to $2327711.4, or have control over 431.06% stake in the company. Gamida Cell Ltd (NASDAQ: GMDA) currently have 132.64M outstanding shares and institutions hold larger chunk of about 31.25% of that. Holding of mutual funds in the company is about 5.52% while other institutional holders and individual stake holders have control over 8.25% and 17.73% of the stake respectively.
The stock has a current market capitalization of $47.22M and its 3Y-monthly beta is at 1.05. It has posted earnings per share of -$0.90 in the same period. It has Quick Ratio of 3.20 while making debt-to-equity ratio of 224.26. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GMDA, volatility over the week remained 20.00% while standing at 11.72% over the month.
Analysts are in expectations that Gamida Cell Ltd (GMDA) stock would likely to be making an EPS of -$0.15 in the current quarter, while forecast for next quarter EPS is -$0.13 and it is -$0.56 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.19 which is -$0.13 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.3 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 37.90% while it is estimated to increase by 27.27% in next year.
Analysts at 4 brokerage firms have issued recommendations for the Gamida Cell Ltd (GMDA)’s stock and average of those rates the stock at a “Strong Buy” and assign it a score of 1.00. Out of those 4 Wall Street analysts, 4 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Alliance Global Partners on November 01, 2021 offering a Buy rating for the stock and assigned a target price of $11 to it.
